Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Braxia Scientific Corp
(OP:
BRAXF
)
0.0060
UNCHANGED
Streaming Delayed Price
Updated: 3:34 PM EDT, Jun 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Braxia Scientific Corp
< Previous
1
2
Next >
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
August 30, 2021
Contents
Via
Benzinga
Braxia Scientific Launches Broad Criteria Trial On Psilocybin For Depression
August 27, 2021
Braxia Scientific Corp. (CSE:BRAX) (OTC:
Via
Benzinga
Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected
August 02, 2021
Last week in Psychedelics:
Via
Benzinga
Braxia Scientific Leadership Receives Funding From Canadian Government To Study Ketamine Therapy
July 28, 2021
Braxia Scientific Corp (CSE:BRAX) (OTC:
Via
Benzinga
Psyched: Cybin And Field Trip Head To Wall Street, AOC Pushes For Federal Psychedelics Research, Off-Label Ketamine Covered By Insurance In Canada
July 26, 2021
Cybin Inc. (NEO: CYBN) (OTCQB:
Via
Benzinga
Canadian Insurance Provider To Cover Off-Label Use Of Ketamine For Treating Depression
July 22, 2021
Braxia Scientific Corp. (CSE:BRAX) (OTC:
Via
Benzinga
How To Invest In "Magic Mushrooms" (Psychedelics)
July 09, 2021
A look at psychedelics as stock market investment opportunities and identifying alternative strategies on how to invest.
Via
Talk Markets
Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies
July 02, 2021
Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential o...
Via
Benzinga
Psyched: Atai Life Sciences Hits Nasdaq, Canada To Fund Ketamine Trials, Mydecine Launches AI Drug-Discovery Platform
June 21, 2021
Atai Life Sciences (NASDAQ: ATAI) made its highly-anticipated Nasdaq...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Psychedelic Drug Stocks Index -21% In May; Now -25% YTD
May 31, 2021
46 psychedelic drug stocks now trade on the various North American stock exchanges and the 11 with the largest market capitalizations make up the Pure-Play Psychedelic Drug Stocks Index.
Via
Talk Markets
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.